genOway is a biotechnology company specializing in the design and development of molecular, cellular and animal research models with high added value for the biopharmaceutical, chemical, agrochemical and agrifood industries as well as for academic research. genOway is a leading company in its market. It bases its development on the combination of a broad and exclusive technological platform and strong intellectual property combining patents and operating licenses. genOway has concluded numerous commercial contracts with the leaders of the pharmaceutical industry (BMS, Janssen, Novartis, Pfizer, etc.), and with the most prestigious academic research centers (King's College and University of Manchester in England, Harvard, Caltech and the National Institute of Health in the United States, the Pasteur Institute in France, the NGFN and the Max Planck Institute in Germany, etc.).
Trade ist aktiv:
Target : €7
SL : €3.43
SL : €3.43
Kommentar:
SL reached! I bought 3.31 €.
2019 Turn-over : €9.4M
2022 Turn-over target : €30M
The potential is enormous!